Maximus sells performance medicine to men, and testosterone is the center of it. Weight loss is here too, and priced aggressively, but it is the adjacent product rather than the point. That ordering matters when you read the pricing, because the two categories are published to completely different standards.

The cheapest entry figure in the market, with an asterisk

Compounded semaglutide starts at $116 and compounded tirzepatide at $198. Those are the lowest figures we have found anywhere, and they are real.

They are also quoted per 28-day supply rather than per month. A calendar month averages 30.44 days, so a 28-day cycle bills about thirteen times a year instead of twelve. Converted to a monthly rate, $116 becomes roughly $126 and $198 becomes roughly $215 — still competitive, and no longer the same number you were comparing.

This is worth being precise about because it is easy to get wrong in both directions. It is not a hidden fee and nothing is concealed: the supply length is printed. But a price per 28 days and a price per month are not the same unit, and every other provider in our set quotes the second one.

The main category has no public price

Testosterone comes in four formats here — a cream, an injectable, an oral, and enclomiphene — usually bundled with anastrozole and lab work. That range is genuinely unusual; most providers in this market offer one format or none.

None of it is priced on a public page. The protocol pages describe the formats and the labs and then hand you to the onboarding flow. So the company’s flagship category is the one you cannot cost out before creating an account, while the sideline category is printed in full.

If testosterone is what you came for, expect to go through intake before you learn the number, and expect labs to be part of the bill rather than an optional extra.

”FDA approved pharmacies”, and what that phrase is not

The weight-loss page describes its supply as coming from “FDA approved pharmacies”. A compounding pharmacy registers with the FDA; that is an administrative fact about the facility.

It says nothing about whether the drug it compounds has been reviewed for safety, effectiveness or manufacturing quality — compounded drugs are not FDA-approved, by definition. The phrasing appears across this whole industry rather than only here, which is exactly why it is worth being able to read past it on any page in this market, including this one.

Here is every plan they publish, what the price covers, and what it does not.